Increased cellular cholesterol efflux in glycogen storage disease type Ia mice: A potential mechanism that protects against premature atherosclerosis

FEBS Letters

Volumn 579, Issue 21, 2005, Pages 4713-4718

  Nguyen, Andrew D ^a   Pan, Chi Jiunn ^a   Shieh, Jeng Jer ^a   Chou, Janice Yang ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Atherosclerosis; ATP binding cassette transporter A1; Cholesterol efflux; Glycogen storage disease type I; Phospholipid; Scavenger receptor class B type I

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; CHOLESTEROL; SCAVENGER RECEPTOR BI;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; CELL TRANSPORT; CHOLESTEROL TRANSPORT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLOGY; GLYCOGEN STORAGE DISEASE TYPE 1; HOMEOSTASIS; MOUSE; MOUSE STRAIN; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTECTION;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS A; ARTERIOSCLEROSIS; CELL LINE; CHOLESTEROL; GLUCOSE-6-PHOSPHATASE; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; ISOENZYMES; LIPIDS; MACROPHAGES; MICE; MICE, KNOCKOUT;

ANIMALIA;

EID: 24044525002     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.07.042     Document Type: Article

References (36)

1. J.Y. Chou, D. Matern, B.C. Mansfield, and Y.-T. Chen Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex Curr. Mol. Med. 2 2002 121 143
2. Y.T. Chen Glycogen storage diseases C.R. Scriver A.L. Beaudet W.S. Sly D. Valle B. Childs K.W. Kinzler B. Vogelstein The Metabolic and Molecular Bases of Inherited Disease Eighth ed. 2001 McGraw-Hill Inc. New York 1521 1551
3. E. Levy, J. Letarte, G. Lepage, L. Thibault, and C.C. Roy Plasma and lipoprotein fatty acid composition in glycogen storage disease type I Lipids 22 1987 381 385
4. E. Levy, L.A. Thibault, C.C Roy, M. Bendayan, G. Lepage, and J. Letarte Circulating lipids and lipoproteins in glycogen storage disease type I with nocturnal intragastric feeding J. Lipid Res. 29 1988 215 226
5. J. Fernandes, P. Alaupovic, and J.M. Wit Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins Pediatr. Res. 25 1989 327 331
6. P.J. Lee, D.S. Celermajer, J. Robinson, S.N. McCarthy, D.J. Betteridge, and J.V. Leonard Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a Atherosclerosis 110 1994 95 100
7. F.L. Ubels, J.P. Rake, J.P. Slaets, G.P. Smit, and A.J. Smit Is glycogen storage disease 1a associated with atherosclerosis Eur. J. Pediatr. 161 Suppl 1 2002 S62 S64
8. C.J. Fielding, and P.E. Fielding Cellular cholesterol efflux Biochim. Biophys. Acta 1533 2001 175 189
9. P.G. Yancey, A.E. Bortnick, G. Kellner-Weibel, M. de la Llera-Moya, M.C. Phillips, and G.H. Rothblat Importance of different pathways of cellular cholesterol efflux Artherioscler. Thromb. Vasc. Biol. 23 2003 712 719
10. B. Jian, M. de la Llera Moya, Y. Ji, N. Wang, M.C. Phillips, J.B. Swaney, A.R. Tall, and G.H. Rothblat Scavenger receptor class B type I as a mediateor of cellular cholesterol efflux to lipoproteins and pohspholipid acceptors J. Biol. Chem. 273 1998 5599 5606
11. M.A. Connelly, and D.L. Williams Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids Curr. Opin. Lipidol. 15 2004 287 295
12. N. Fournier, J.L. Paul, V. Atger, A. Cogny, T. Soni, M. de la Llera-Moya, G. Rothblat, and N. Moatti HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum Arterioscler. Thromb. Vasc. Biol. 17 1997 2685 2691
13. P.G. Yancey, M.A. Kawashiri, R. Moore, J.M. Glick, D.L. Williams, M.A. Connelly, D.J. Rader, and G.H. Rothblat In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux J. Lipid Res. 45 2004 337 346
14. R.M. Lawn, D.P. Wade, M.R. Garvin, X. Wang, K. Schwartz, J.G. Porter, J.J. Seilhamer, A.M. Vaughan, and J.F. Oram The Tangier disease gene product ABCA1 controls the cellular apolipoprotein-mediated lipid removal pathway J. Clin. Invest. 104 1999 R25 R31
15. J.F. Oram Tangier disease and ABCA1 Arterioscler. Thromb. Vasc. Biol. 23 2002 720 727
16. K.A. Rye, and P.J. Barter Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I Arterioscler. Thromb. Vasc. Biol. 24 2004 421 428
17. N. Duverger, G. Tremp, J.M. Caillaud, F. Emmanuel, G. Castro, J.C. Fruchart, A. Steinmetz, and P. Denefle Protection against atherogenesis in mice mediated by human apolipoprotein A-IV Science 273 1996 966 968
18. R.D. Cohen, L.W. Castellani, J.H. Qiao, B.J. Van Lenten, A.J. Lusis, and K. Reue Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV J. Clin. Invest. 99 1997 1906 1916
19. L.K. Curtiss, and W.A. Boisvert Apolipoprotein E and atherosclerosis Curr. Opin. Lipidol. 11 2000 243 251
20. P. Alaupovic, and J. Fernandes The serum apolipoprotein profile of patients with glucose-6-phosphatase deficiency Pediatr. Res. 19 1985 380 384
21. K.-J. Lei, H. Chen, C.-J. Pan, J.M. Ward, B. Mosinger, E.J. Lee, H. Westphal, and J.Y. Chou Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type 1a mouse Nat. Genet. 13 1996 203 209
22. T.S Mikkola, M.S. Anthony, T.B. Clarkson, and R.W. St Clair Serum cholesterol efflux potential is an independent predictor of coronary artery atherosclerosis Atherosclerosis 170 2003 31 38
23. 2+ precipitation procedure for quantitation of high-density- lipoprotein cholesterol Clin. Chem. 28 1982 1379 1388
24. Y. Ji, B. Jian, N. Wang, Y. Sun, M.L. Moya, M.C. Phillips, G.H. Rothblat, J.B. Swaney, and A.R. Tall Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux J. Biol. Chem. 272 1997 20982 20985
25. A.E. Bortnick, G.H. Rothblat, G. Stoudt, K.L. Hoppe, L.J. Royer, J. McNeish, and O.L. Francone The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines J. Biol. Chem. 275 2000 28634 28640
26. M. de la Llera Moya, V. Atger, J.L. Paul, N. Fournier, N. Moatti, P. Giral, K.E. Friday, and G. Rothblat A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer Arterioscler. Thromb. Vasc. Biol. 14 1994 1056 1065
27. S.W. Sakr, D.L. Williams, G.W. Stoudt, M.C. Phillips, and G.H. Rothblat Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP Biochim. Biophys. Acta 1438 1999 85 98
28. P.J. Barter, H.B. Brewer Jr., M.J. Chapman, C.H. Hennekens, D.J. Rader, and A.R. Tall Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis Arterioscler. Thromb. Vasc. Biol. 23 2003 160 167
29. N. Fournier, V. Atger, J.L. Paul, M. Sturm, N. Duverger, G.H. Rothblat, and N. Moatti Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum Arterioscler. Thromb. Vasc. Biol. 20 2000 1283 1292
30. T. Arai, N. Wang, M. Bezouevski, C. Welch, and A.R. Tall Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene J. Biol. Chem. 274 1999 2366 2371
31. Y. Ueda, E. Gong, L. Royer, P.N. Cooper, O.L. Francone, and E.M. Rubin Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics J. Biol. Chem. 275 2000 20368 20373
32. K.F. Kozarsky, M.H. Donahee, J.M. Glick, M. Krieger, and D.J. Rader Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse Arterioscler. Thromb. Vasc. Biol. 20 2000 721 727
33. W. Zhang, P.G. Yancey, Y.R. Su, V.R. Babaev, Y. Zhang, S. Fazio, and M.F. Linton Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice Circulation 108 2003 2258 2263
34. S.D. Covey, M. Krieger, W. Wang, M. Penman, and B.L. Trigatti Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells Arterioscler. Thromb. Vasc. Biol. 23 2003 1589 1594
35. R.J. Aiello, D. Brees, P.A.K. Bourassa, L. Royer, S. Lindsey, T. Coskran, M. Haghpassand, and O.L. Francone Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages Arterioscler. Thromb. Vasc. Biol. 22 2002 630 637
36. N. Wang, D. Lan, W. Chen, F. Matsuura, and A.R. Tall ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins Proc. Natl. Acad. Sci. USA 101 2004 9774 9779